MLH1 p.Ile219Phe
Variant summary
The NM_000249.4(MLH1):c.655A>T (p.Ile219Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene MLH1 is a tumor suppressor gene (CancerMine: 10 TSG, 4 oncogene, 3 driver citations). The gene MLH1 is a known oncogene (CancerMine: 10 TSG, 4 oncogene, 3 driver citations). The gene MLH1 is a cancer driver gene (CancerMine: 10 TSG, 4 oncogene, 3 driver citations). The variant allele was found at a cumulative frequency of 0.00000137 (AC=2) in the gnomAD database across 1,460,796 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000003. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.I219L: Benign (ClinVar VariationId 90305, 3 stars); p.I219M: Uncertain_significance (ClinVar VariationId 489902, 1 star); p.I219T: Uncertain_significance (ClinVar VariationId 483584, 2 stars); p.I219V: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 920597); p.I219V: Benign (ClinVar VariationId 36557, 3 stars)
Frequency
Consequence
NM_000249.4 missense
Scores
Clinical Significance
Conservation
Publications
- Lynch syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, G2P, Orphanet
- Lynch syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics
- Muir-Torre syndromeInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, G2P, Ambry Genetics
- mismatch repair cancer syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- Lynch syndrome 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- ovarian cancerInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- malignant pancreatic neoplasmInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- rhabdomyosarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- prostate cancerInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Uncertain_significance. The variant received 3 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O3Absent or very rare in population | Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = 0.000000, AC = 2 — absent/extremely rare (O3 moderate [+2]) | ||
| O6Computational evidence supports deleterious effect | Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000249.4. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
MLH1 | MANE Select | c.655A>T p.Ile219Phe | missense | Exon 8 of 19 | Prot: NP_000240.1 UniProt: | |
MLH1 | c.655A>T p.Ile219Phe | missense | Exon 8 of 18 | Prot: NP_001341557.1 UniProt: | ||
MLH1 | c.556A>T p.Ile186Phe | missense | Exon 7 of 18 | Prot: NP_001341558.1 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
MLH1 | TSL:1MANE Select | c.655A>T p.Ile219Phe | missense | Exon 8 of 19 | Prot: ENSP00000231790.3 UniProt: | |
MLH1 | TSL:1 | c.655A>T p.Ile219Phe | missense | Exon 8 of 17 | Prot: ENSP00000416687.3 UniProt: | |
MLH1 | TSL:1 | c.655A>T p.Ile219Phe | missense | Exon 8 of 15 | Prot: ENSP00000416476.2 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 5 sources | |||||
GnomAD3 genomes | Cov:32 | ||||
GnomAD4 exome | AF: 0.00000137 | AC:2 | Hom:0 | AN:1460796 | Cov:32 |
GnomAD4 genome | Cov:32 | ||||
TOPMed (Bravo) | AF: 0.00000756 | ||||
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.00 | AC:0 | Hom:31907 | AN:710128 | |
ClinVar
Not reported inComputational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 20 | |
AlphaMissense | Uncertain | 0.34 | |
BayesDel_addAF | Pathogenic | 0.28 | D |
BayesDel_noAF | Pathogenic | 0.16 | |
CADD | Uncertain | 24 | |
DANN | Uncertain | 0.99 | |
DEOGEN2 | Pathogenic | 0.82 | D |
Eigen | Pathogenic | 0.71 | |
Eigen_PC | Uncertain | 0.65 | |
FATHMM_MKL | Uncertain | 0.93 | D |
FuncVEP CTI | Pathogenic | 0.51 | |
GPN-Star LLR | N/A | -8.7 | |
GPN-Star score | N/A | 8.7 | |
LIST_S2 | Pathogenic | 0.99 | D |
M_CAP | Uncertain | 0.23 | D |
MetaRNN | Pathogenic | 0.83 | D |
MetaSVM | Uncertain | 0.56 | D |
Mutation Taster | N/A | 34/66 | disease causing |
MutationAssessor | Pathogenic | 3.1 | M |
PhyloP100 | Benign | 2.0 | |
popEVE | Benign | -3.5 | |
PrimateAI | Uncertain | 0.51 | T |
PROVEAN | Uncertain | -3.3 | D |
REVEL | Pathogenic | 0.82 | |
Sift | Uncertain | 0.0030 | D |
Sift4G | Uncertain | 0.0060 | D |
Varity_R | N/A | 0.65 | |
VESM-3B | Benign | -11 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.010 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.